Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Obstetrics and Gynecology
|
April 12, 2023
Three-tiered fetal heart rate interpretation system and adverse neonatal and maternal outcomes: a systematic review and meta-analysis
Fabrizio Zullo, Daniele Di Mascio, Nandini Raghuraman, et al.
Leukemia
|
October 28, 2025
ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/- lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study
Mouhamad Khouja, Britta Kehden, Derek Blair, et al.
Journal of Minimally Invasive Gynecology
|
January 27, 2022
Evaluating Surgical Complexity of Endoscopic Hysterectomy: An Inter-rater and Intra-rater Agreement Study of Novel Scoring Tool
Meenal Misal, Marlene Girardo, Sadikah Behbehani, et al.
Stem Cell Reports
|
February 24, 2015
Defined conditions for the isolation and expansion of basal prostate progenitor cells of mouse and human origin
Thomas Höfner, Christian Eisen, Corinna Klein, et al.
Molecular Systems Biology
|
November 29, 2017
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations
Julia Jabs, Franziska M Zickgraf, Jeongbin Park, et al.
Blood
|
June 27, 2023
Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study
David Belada, Katerina Kopeckova, Juan Miguel Bergua Burgues, et al.
Molecular Oncology
|
October 25, 2017
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor
Steven R Whittaker, Clare Barlow, Mathew P Martin, et al.
Oncogene
|
October 25, 2018
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Oncogene
|
June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Breast Cancer Research : BCR
|
November 27, 2015
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features
Andrea Aloia, Evgeniya Petrova, Stefan Tomiuk, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Obstetrics and Gynecology
|
April 12, 2023
Three-tiered fetal heart rate interpretation system and adverse neonatal and maternal outcomes: a systematic review and meta-analysis
Fabrizio Zullo, Daniele Di Mascio, Nandini Raghuraman, et al.
Leukemia
|
October 28, 2025
ctDNA dynamics demonstrates rapid treatment response to tafasitamab + R-CHOP +/- lenalidomide and predicts outcome in diffuse large B-cell lymphoma: results from the phase 1b First-MIND study
Mouhamad Khouja, Britta Kehden, Derek Blair, et al.
Journal of Minimally Invasive Gynecology
|
January 27, 2022
Evaluating Surgical Complexity of Endoscopic Hysterectomy: An Inter-rater and Intra-rater Agreement Study of Novel Scoring Tool
Meenal Misal, Marlene Girardo, Sadikah Behbehani, et al.
Stem Cell Reports
|
February 24, 2015
Defined conditions for the isolation and expansion of basal prostate progenitor cells of mouse and human origin
Thomas Höfner, Christian Eisen, Corinna Klein, et al.
Molecular Systems Biology
|
November 29, 2017
Screening drug effects in patient-derived cancer cells links organoid responses to genome alterations
Julia Jabs, Franziska M Zickgraf, Jeongbin Park, et al.
Blood
|
June 27, 2023
Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study
David Belada, Katerina Kopeckova, Juan Miguel Bergua Burgues, et al.
Molecular Oncology
|
October 25, 2017
Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor
Steven R Whittaker, Clare Barlow, Mathew P Martin, et al.
Oncogene
|
October 25, 2018
Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Oncogene
|
June 1, 2019
Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer
Steve Wagner, Georgios Vlachogiannis, Alexis De Haven Brandon, et al.
Breast Cancer Research : BCR
|
November 27, 2015
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features
Andrea Aloia, Evgeniya Petrova, Stefan Tomiuk, et al.
Page
of 2